Inactive Instrument

Transcripts NeoStem Inc NYSE

Stocks

NBS

US6406503051

Biotechnology & Medical Research

End-of-day quote NYSE
- ^USD	-

09-17	Lisata Therapeutics, Inc.(NasdaqCM:LSTA) added to NASDAQ Composite Index	CI
09-17	Lisata Therapeutics, Inc. (Nasdaq: LSTA) acquired Marea Therapeutics, Inc. for approximately $240 million.	CI

Transcripts

11-07	Lisata Therapeutics, Inc., Q3 2025 Earnings Call, Nov 06, 2025
08/08/25	Lisata Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025
08/05/25	Lisata Therapeutics, Inc., Q1 2025 Earnings Call, May 08, 2025
27/02/25	Lisata Therapeutics, Inc., 2024 Earnings Call, Feb 27, 2025
12/11/24	Lisata Therapeutics, Inc., Q3 2024 Earnings Call, Nov 12, 2024
12/08/24	Lisata Therapeutics, Inc., Q2 2024 Earnings Call, Aug 12, 2024
09/05/24	Lisata Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
10/04/24	Lisata Therapeutics, Inc. - Special Call
29/02/24	Lisata Therapeutics, Inc., 2023 Earnings Call, Feb 29, 2024
02/11/23	Lisata Therapeutics, Inc., Q3 2023 Earnings Call, Nov 02, 2023
15/08/23	Lisata Therapeutics, Inc., Q2 2023 Earnings Call, Aug 15, 2023
21/06/23	Lisata Therapeutics, Inc. - Special Call
09/05/23	Lisata Therapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023
30/03/23	Lisata Therapeutics, Inc., Q4 2022 Earnings Call, Mar 30, 2023
10/11/22	Lisata Therapeutics, Inc., Q3 2022 Earnings Call, Nov 10, 2022
14/08/22	Caladrius Biosciences, Inc. - Special Call
04/08/22	Caladrius Biosciences, Inc., Q2 2022 Earnings Call, Aug 04, 2022
24/05/22	Caladrius Biosciences, Inc. - Special Call
05/05/22	Caladrius Biosciences, Inc., Q1 2022 Earnings Call, May 05, 2022
27/04/22	Caladrius Biosciences, Inc., Cend Therapeutics Inc. - M&A Call
22/03/22	Caladrius Biosciences, Inc., Q4 2021 Earnings Call, Mar 22, 2022
04/11/21	Caladrius Biosciences, Inc., Q3 2021 Earnings Call, Nov 04, 2021
05/08/21	Caladrius Biosciences, Inc., Q2 2021 Earnings Call, Aug 05, 2021
06/05/21	Caladrius Biosciences, Inc., Q1 2021 Earnings Call, May 06, 2021
25/02/21	Caladrius Biosciences, Inc., Q4 2020 Earnings Call, Feb 25, 2021